Wednesday, September 19, 2012 8:01:45 PM
BIIB. The New England Journal of Medicine Publishes Pivotal Data Demonstrating Efficacy and Safety of Oral BG-12 (Dimethyl Fumarate) in Multiple Sclerosis
Results of Phase 3 DEFINE and CONFIRM Studies Support Dimethyl Fumarate’s Potential as a Strong Option for MS Treatment
http://finance.yahoo.com/news/england-journal-medicine-publishes-pivotal-210000550.html
Results of Phase 3 DEFINE and CONFIRM Studies Support Dimethyl Fumarate’s Potential as a Strong Option for MS Treatment
http://finance.yahoo.com/news/england-journal-medicine-publishes-pivotal-210000550.html
The Penny Ticker.
http://investorshub.advfn.com/The-Penny-Ticker-17412/
5-bagger contest on Dawgg.
http://investorshub.advfn.com/%22Dawgg%22-21519/
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
